Results 101 to 110 of about 50,666 (222)

Non-functional paraganglioma of the urinary bladder: a case report

Journal of Medical Case Reports, 2010
Introduction Paragangliomas that originate from the urinary bladder are extremely rare. In most series, bladder paragangliomas often cause micturitional attacks.
Gao Yi, Liu Yu-Shan, Chen Ming, Xu Dan-Feng, Cui Xin-Gang   +4 more
doaj   +1 more source

Epilepsy Phenotype and EEG Finding of Rhythmic High‐Amplitude Delta With Superimposed Spikes (RHADS) in Succinate Dehydrogenase Deficiency

JIMD Reports, Volume 67, Issue 2, March 2026.
ABSTRACT Succinate dehydrogenase (SDH) serves a dual function as complex II of the electron transport chain and an enzyme of the tricarboxylic acid cycle. Pathogenic variants in subunits of SDH result in diverse clinical presentations, including typically autosomal recessive neurodegenerative disorders. Biallelic variants in the SDHA subunit most often
Aaron B. Bowen, Chiadika Nwanze, Cesar Alves, Lance Rodan, Anna Lecticia Pinto, Melissa A. Walker, Irina Anselm, Phillip L. Pearl   +7 more
wiley   +1 more source

Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical Medicine

Journal of Clinical Medicine, 2018
Pheochromocytoma (PCC) and sympathetic paraganglioma (PGL) are rare neuroendocrine tumors characterized by catecholamine production in the adrenal medulla and extra-adrenal paraganglia.
N. Kimura, K. Takekoshi, M. Naruse
semanticscholar   +1 more source

Advances and Prospects of Stereotactic Radiosurgery and Stereotactic Ablative Body Radiotherapy: Evolving Paradigms in Precision Oncology

Med Research, Volume 2, Issue 1, Page 157-180, March 2026.
The graphical abstract outlines the progressive development and impact of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). Technological Evolution illustrates the transition from brachytherapy with single‐dose, LDR/HDR schedules to fractionated radiotherapy, three‐dimensional conformal radiotherapy (3DCRT) and Gamma Knife ...
Jing Zhang, Wenhao Xu, Weiqing Lu, Yingxuan Lin, Luoxi He, Zonglin Lv, Yiliyaer Nuerrula, Zouting, Zhen Zhang, Hailiang Zhang, Xuejun Ma   +10 more
wiley   +1 more source

Hypertension secondary to paraganglioma: case report and review of the literature

Iatreia, 2016
We report the case of a 25 year-old man with a history of transient stroke during adolescence, and longstanding uncontrolled hypertension who presented with palpitations, diaphoresis and headache.
Rubio-Marín, Andrea Constanza, Orjuela, Alba Dayana, Rascovsky, Melissa, Rosselli, Diego   +3 more
doaj   +1 more source

Recommendations for bone‐directed therapy in patients with neuroendocrine tumour skeletal metastases at the New Zealand National Neuroendocrine Tumour Multidisciplinary Meeting

Internal Medicine Journal, Volume 56, Issue 3, Page 465-468, March 2026.
Abstract The role of anti‐resorptive agents in patients with bone metastases from neuroendocrine neoplasms is unclear. Our aim was to review bone‐specific treatment recommendations by the New Zealand National Neuroendocrine Tumour Multidisciplinary Meeting (MDM).
Gayle Radley, Marianne S Elston, Ben Lawrence, Veronica Boyle   +3 more
wiley   +1 more source

Paraganglioma in the bladder: a case report

Journal of Medical Case Reports, 2017
Background Paraganglioma is an extra site of pheochromocytoma. Paraganglioma in the bladder is a very rare disease accounting for 0.06% of all bladder tumors.
Genta Iwamoto, Takashi Kawahara, Mikiko Tanabe, Sahoko Ninomiya, Daiji Takamoto, Taku Mochizuki, Shinnosuke Kuroda, Teppei Takeshima, Koji Izumi, Yusuke Hattori, Jun-ichi Teranishi, Yasushi Yumura, Yasuhide Miyoshi, Hiroji Uemura   +13 more
doaj   +1 more source

Targeted Radionuclide Therapy for Patients with Metastatic Pheochromocytoma and Paraganglioma: From Low-Specific-Activity to High-Specific-Activity Iodine-131 Metaiodobenzylguanidine

Cancers, 2019
Low-specific-activity iodine-131–radiolabeled metaiodobenzylguanidine (I-131-MIBG) was introduced last century as a potential systemic therapy for patients with malignant pheochromocytomas and paragangliomas.
C. Jimenez, W. Erwin, B. Chasen
semanticscholar   +1 more source

Rectal Paraganglioma

Internal Medicine, 2019
A 57-year-old woman was admitted with lower abdominal pain and bloody bowel discharge. She was diagnosed with rectal tumor by colonoscopy, and a biopsy was performed. Surgery was performed, resulting in a diagnosis of rectal paraganglioma. Since recurrence was confirmed three years later, reoperation was done, and chemotherapy with cyclophosphamide ...
Araki, Tomonori, Takeshita, Shigeyuki, Kawasaki, Hiroko, Kusumoto, Koichiro, Ohata, Kazuyuki, Shigematsu, Kazuto, Shigeno, Masaya   +6 more
openaire   +3 more sources

Prognostic Value of a Histopathological Scoring System and the Ki67 Proliferation Index in Dogs With Phaeochromocytoma

Veterinary and Comparative Oncology, Volume 24, Issue 1, Page 11-20, March 2026.
ABSTRACT Canine phaeochromocytomas (PCCs) are neuroendocrine tumours with malignant potential. Metastatic disease remains the sole definitive evidence of malignancy. Histopathological criteria to predict long‐term survival have not been established in dogs.
Marit F. van den Berg, Aitor Martínez Ruiz, Maurice M. J. M. Zandvliet, Sebastiaan A. van Nimwegen, Hans S. Kooistra, Sara Galac, Guy C. M. Grinwis   +6 more
wiley   +1 more source